Everence Capital Management’s Clorox CLX Stock Holding History

Everence Capital Management’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$439K	Buy	4,240 +899	+27%	+$102K	0.03%	420
2025 Q4	$337K	Buy	3,341 +371	+12%	+$40.3K	0.02%	542
2025 Q3	$366K	Buy	+2,970	New	+$369K	0.02%	514
2025 Q1	–	Sell	-1,690	Closed	-$274K	–	795
2024 Q4	$274K	Sell	1,690 -2,660	-61%	-$435K	0.02%	623
2024 Q3	$709K	Hold	4,350	–	–	0.04%	315
2024 Q2	$643	Hold	4,350	–	–	0.04%	319
2024 Q1	$666	Hold	4,350	–	–	0.04%	330
2023 Q4	$620K	Sell	4,350 -2,800	-39%	-$373K	0.04%	332
2023 Q3	$937	Buy	7,150 +5,130	+254%	+$780K	0.07%	224
2023 Q2	$320K	Hold	2,020	–	–	0.03%	500
2023 Q1	$320	Sell	2,020 -10	-0.5%	-$1.5K	0.03%	512
2022 Q4	$285	Buy	+2,030	New	+$288K	0.02%	568
2022 Q1	–	Sell	-2,790	Closed	-$486K	–	744
2021 Q4	$486K	Buy	+2,790	New	+$465K	0.04%	432
2021 Q2	–	Sell	-1,450	Closed	-$280K	–	729
2021 Q1	$280K	Hold	1,450	–	–	0.03%	585
2020 Q4	$293K	Buy	+1,450	New	+$300K	0.03%	534
2019 Q4	–	Sell	-2,852	Closed	-$433K	–	677
2019 Q3	$433K	Hold	2,852	–	–	0.07%	307
2019 Q2	$437K	Hold	2,852	–	–	0.07%	302
2019 Q1	$458K	Hold	2,852	–	–	0.08%	275
2018 Q4	$440K	Hold	2,852	–	–	0.1%	218
2018 Q3	$429K	Hold	2,852	–	–	0.09%	250
2018 Q2	$386K	Hold	2,852	–	–	0.08%	266
2018 Q1	$380K	Hold	2,852	–	–	0.08%	263
2017 Q4	$424K	Buy	+2,852	New	+$388K	0.09%	242

Other funds holding CLX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Everence Capital Management's CLX Position: Q1 2026 in Review

Everence Capital Management increased its Clorox (CLX) stake by 27% in Q1 2026, buying an estimated $102K and bringing the position to 4,240 shares worth $439K. The position accounts for 0.03% of the portfolio, ranked #420.

Everence Capital Management first reported a position in CLX in Q4 2017 and has held it in 23 quarters since. The position peaked at $709K in Q3 2024. 1,082 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

Everence Capital Management held 4,240 shares of Clorox worth $439K as of Q1 2026.
Everence Capital Management bought 899 Clorox shares in Q1 2026, an estimated $102K.
Clorox made up 0.03% of Everence Capital Management's portfolio in Q1 2026, its #420 holding.
Everence Capital Management first reported a position in Clorox in Q4 2017 and has held it in 23 quarters since.
Everence Capital Management's Clorox position peaked at $709K in Q3 2024.
1,082 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Everence Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.